EXPERT VIEW: Four Priorities For Regulatory Convergence In Asia
This article was originally published in PharmAsia News
Executive Summary
The 2015 Asia Regulatory Conference (ARC) held on Feb.4-5 in Taiwan brought together over 250 stakeholders from regulatory, pharmaceutical, academic, civil society, international and non-governmental organizations, including policy experts from Asia. They met on the understanding that no single state, regulatory authority or company within the pharmaceutical industry can meet current regulatory challenges alone.